Growth Hormone Disorder: Clinical Trials

11 trials for Growth Hormone Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 311Completed 11

Follow Growth Hormone Disorder: new trials by email Literature Review of Growth Hormone Disorder trials Research Report on Growth Hormone Disorder

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency
somapacitan, Norditropin - Growth Hormone Disorder, Adult Growth Hormone Deficiency
Phase 3CompletedNovo Nordisk A/S622017-03-032020-11-23
A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency
somapacitan, somatropin - Adult Growth Hormone Deficiency, Growth Hormone Disorder
Phase 3CompletedNovo Nordisk A/S922015-02-122020-07-09
Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.
somapacitan, somatropin, placebo - Growth Hormone Disorder, Adult Growth Hormone Deficiency
Phase 3CompletedNovo Nordisk A/S3012014-10-312020-11-23
Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)
somatropin - Growth Hormone Disorder, Adult Growth Hormone Deficiency
Phase 3CompletedNovo Nordisk A/S862004-11-012016-11-17
Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)
somatropin - Growth Hormone Disorder, Adult Growth Hormone Deficiency
Phase 3CompletedNovo Nordisk A/S1122003-12-062017-02-28
Growth Hormone Deficiency in Adults (GHDA)
somatropin - Growth Hormone Disorder, Adult Growth Hormone Deficiency
Phase 3CompletedNovo Nordisk A/S1212003-05-312017-02-28
Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children
somatropin - Growth Hormone Disorder, Pituitary Dwarfism
Phase 3CompletedNovo Nordisk A/S1492003-05-012017-01-18
Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency
somatropin - Growth Hormone Disorder, Adult Growth Hormone Deficiency
Phase 3CompletedNovo Nordisk A/S1612002-02-012017-01-13
Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
somatropin - Growth Hormone Disorder, Growth Hormone Deficiency in Children
Phase 3CompletedNovo Nordisk A/S782001-05-082017-02-28
Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
somatropin - Growth Hormone Disorder, Growth Hormone Deficiency in Children
Phase 3CompletedNovo Nordisk A/S1682000-10-232017-02-27
Effect of Growth Hormone in Children With Growth Hormone Deficiency
somatropin - Growth Hormone Disorder, Growth Hormone Deficiency in Children
Phase 3CompletedNovo Nordisk A/S1732000-08-012017-01-18

Narrower conditions

Dwarfism, Pituitary (8)  ·  Genetic Diseases, Inborn (1)  ·  Growth Disorders (1)  ·  Turner Syndrome (1)

Broader conditions

Endocrine System Diseases (9)  ·  Bone Diseases (8)  ·  Bone Diseases, Developmental (8)  ·  Bone Diseases, Endocrine (8)  ·  Brain Diseases (8)  ·  Central Nervous System Diseases (8)  ·  Dwarfism (8)  ·  Hypopituitarism (8)  ·  Hypothalamic Diseases (8)  ·  Musculoskeletal Diseases (8)  ·  Nervous System Diseases (8)  ·  Pituitary Diseases (8)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Chromosome Disorders (1)

Interventions

Human Growth Hormone (11)  ·  somapacitan (3)  ·  NNC0195-0092 (1)

Sponsors

Novo Nordisk A/S (11)

Countries

Japan (6)  ·  United States (4)  ·  Germany (3)  ·  Sweden (3)  ·  United Kingdom (3)  ·  Australia (2)  ·  France (2)  ·  Israel (2)  ·  Norway (2)  ·  Poland (2)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Hungary (1)

Results publications

PMID 36380045, PMID 18395480, PMID 17356043, PMID 22924571, PMID 32022863, PMID 32603494, PMID 39991735

NIH funding

2014 (1)